Company Overview of LXR Biotechnology Inc.
LXR Biotechnology, Inc. was engaged in the research and development of therapeutics to treat diseases caused by or associated with apoptosis, as of September 30, 1999. The company’s compounds included HK-Cardiosol™, CP-Cardiosol™, and Elirex™.
3095 Richmond Parkway
Richmond, CA 94806
Key Executives for LXR Biotechnology Inc.
LXR Biotechnology Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Imreg, Inc.||United States|
|CymoGen Dx, LLC||United States|
|Vascular Strategies LLC||United States|
|Cold Genesys Inc||United States|
|Immuno Concepts N.A. Ltd.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact LXR Biotechnology Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.